UBS upgrades Thermo Fisher Scientific stock rating on growth outlook
What it means
- What to watch: Thermo Fisher Scientific Inc. (TMO) was upgraded; the new price target against where shares already trade is the gap that tells you how bold the call is.
- How the stock is trading: $TMO -1.22% in the latest session.
- Timing: It landed before the opening bell — early risers had it with their coffee, and the next session was the first that could react.
Where the stock stands
$TMO last traded at $700.50, -1.22% on the session. That puts it 1.6% shy of its 52-week high of $711.85 and 61% clear of its low of $435.27 — within a tenth of its 52-week high. Over the year it has ranged 64% from low to high: a wide band — moves of several percent in a week come with the territory. These are latest-session quotes, not live prices — the live tape is on the $TMO page.
How much coverage it is getting
Nothing else on $TMO in the last 30 days: this is the only story Wook has filed, so there is no run to measure it against yet. 12 related stories from the same name or desk are listed beside this one.
The bigger picture
With earnings, the number matters less than the number versus expectations — and guidance often matters more than both. A beat paired with a soft outlook can still get a cold reception. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it watches. The scanner equivalent of a quiet night shift.
What to watch next
For the receipts, the $TMO page has the full chart, the filings and the valuation model these figures come from. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. Wook AI, above, can pull live figures and run the numbers on request — how far $TMO is from its high, or how this week's coverage compares.
How this analysis was made
Investing.com published it, and Wook filed it under Earnings. It reads bullish at medium severity because of “growth” and “upgrade” in the wording, with nothing on the bearish side to offset them. It was matched to $TMO. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on September 9, 2026. $TMO has moved +15.65% ($605.69 to $700.50). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.